Evidence map›Paper›PMID 29285198›Full record

ArticleOncology letters2018

Total alkaloids of

Mimi Li, Jiying Wang, Biwen Mo, Jinrong Zeng, Dong Yao, Feng Chen, Ming Jiang, Lizong Rao, Yinjun Du

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. International journal of molecular sciences · 2023
    Review
  2. Review
  3. Frontiers in pharmacology · 2020
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mimi LiInstitute of Respiratory Diseases, Guilin Medical University, Guilin, Guangxi 541000, P.R. China.
Jiying WangDepartment of Respiratory, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541000, P.R. China.
Biwen MoDepartment of Respiratory, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541000, P.R. China.
Jinrong ZengDepartment of Respiratory, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541000, P.R. China.
Dong YaoDepartment of Respiratory, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541000, P.R. China.
Feng ChenDepartment of Respiratory, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541000, P.R. China.
Ming JiangDepartment of Respiratory, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541000, P.R. China.
Lizong RaoInstitute of Respiratory Diseases, Guilin Medical University, Guilin, Guangxi 541000, P.R. China.
Yinjun DuInstitute of Respiratory Diseases, Guilin Medical University, Guilin, Guangxi 541000, P.R. China.
Guilin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell division cycle 42 (Cdc42) is a critical regulator, which functions in cancer metastasis. Numerous previous studies have demonstrated that vav guanine nucleotide exchange factor 1 (Vav1) is ectopically expressed in numerous types of human malignancies and have suggested that Vav1 may efficiently promote the formation of invadopodia and matrix degradation by regulating the activation of Cdc42. Total alkaloids of

Indexed as

A549 cellscell division cycle 42invasionmigrationtotal alkaloids of Corydalis saxicola buntingvav guanine nucleotide exchange factor 1

Identifiers

PMID29285198
PMCPMC5738710
OpenAlexW2766778341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.